At the Intersection: Jacob and Eli Berlin on How Terray Merges Chemistry and Compute to Drive Drug Discovery

About this episode

Jacob and Eli Berlin discuss how Terray is transforming drug discovery through the integration of chemistry and AI.

Working at the intersection of chemistry, machine learning, and AI, Jacob and Eli Berlin discuss how Terray is transforming drug discovery. By building and testing small molecules at a massive scale, Terray accelerates candidate discovery in uncharted chemical space and redefines what an AI-native biotech can achieve.

People in this episode

Guests: Jacob Berlin, Eli Berlin

Topics covered

• drug discovery
• machine learning
• chemistry
• AI
• biotechnology

Keywords

• drug discovery
• machine learning
• AI
• chemistry
• biotech

Mentioned in this episode

Organizations: Terray, AI-native biotech

More episodes of The Future of Healthcare AI

• Spanning Every Surface: Google Cloud’s Aashima Gupta on AI, Access, and Adaptive Healthcare · May 25, 2026 · 30 min
• Medicare meets AI: Andrew Toy on How Clover Health Superpowers Clinicians and Enables Earlier Intervention · May 10, 2026 · 35 min
• Reprogramming Age: Jacob Kimmel on How NewLimit Uses AI to Extend Healthspans · May 3, 2026 · 39 min
• Where Pharma Wins: Jaswinder Chadha on How Axtria Uses AI to Drive Commercial Ops and Outcomes · January 5, 2026 · 27 min
• Operationalizing AI: Aman Wasan on How the ArisGlobal Digital Platform Powers Safer, Smarter Therapies · November 17, 2025 · 28 min
• The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery · November 12, 2025 · 33 min